Table 1 shows the basic patient characteristics. Demographics were similar with regard to sex, age, hepatitis virus infection, α-fetoprotein (AFP) level, tumor size, tumors numbers, cirrhosis, combined TACE therapy, surgery or ablation treatment, tumor differentiation, satellite nodules, venous invasion, perineural invasion, capsule invasion, disease progression status, and PFS time between the train and validation cohorts (p > 0.05). This evidence concerns the gene AFP and neoplasm.